Wavelength

Wavelength Pharmaceuticals is a world-class developer and manufacturer of Active Pharmaceutical Ingredients (APIs). More than 250 pharmaceutical manufacturers worldwide rely on Wavelength for the development, production, and reliable supply of APIs. Its current product portfolio consists of approximately 40 differentiated commercial APIs, with total API production exceeding 250 metric tons annually. The company provides top-tier API solutions, offering comprehensive technical and in-depth regulatory support throughout the entire product lifecycle—from project initiation to commercial production—for customers in over 50 countries.Wavelength is an expert in complex chemistry, process development, scale-up, crystal forms, and particle design, providing customized solutions tailored to meet individual customer needs. This includes full-scale API custom synthesis and manufacturing services from preclinical stages, along with complete regulatory support. Its API CDMO services embody a strong culture of quality, regulatory compliance, robust supply chain management, and scalable development methods, which have supported Wavelength’s API business for decades. Customers can be assured of sustained regulatory compliance and reliable, uninterrupted supply.Wavelength is committed to being "Always Aligned" with its customers' needs in the ever-evolving and increasingly competitive global pharmaceutical market, delivering exceptional value to hundreds of customers worldwide. Building on a long tradition of excellence and a global leadership position in selected molecules, Wavelength possesses all the capabilities and flexibility needed to reliably meet changing customer demands and adapt to their growth.